Chemoprevention for colorectal tumorigenesis associated with chronic colitis in mice via apoptosis

J Exp Clin Cancer Res. 2003 Mar;22(1):41-6.

Abstract

The mechanism of the suppressive effect of nonsteroidal anti-inflammatory drugs in azoxymethan and dextran sulfate sodium-induced colonic aberrant crypt foci/tumors associated with chronic colitis in mice was studied. With administration of sulindac, a cyclooxygenase-1 and -2 inhibitor, the mean number of colonic aberrant crypt foci/tumors was significantly smaller than that of controls. There was no significant difference in prostaglandin E2 content in the colonic mucosa between the groups. Furthermore, nimesulid, a cyclooxygenase-2 selective inhibitor, also suppressed colonic aberrant crypt foci/tumors as well as sulindac. Administration of nimesulid caused apoptosis indices to be significantly higher along with cyclooxygenase-2 expression being significantly lower than in controls. Apoptosis indices of 400 ppm group of nimesulid were significantly higher than that of 200 ppm group. Nonsteroidal anti-inflammatory drugs distinctly suppress the occurrence of aberrant crypt foci/tumors in this murine colitis-associated neoplasia model. Induction of apoptosis is a more important factor for chemoprevention than this reduction of prostaglandin E2.

MeSH terms

  • Animals
  • Apoptosis
  • Azoxymethane
  • Carcinogens
  • Chemoprevention / methods*
  • Chronic Disease
  • Colitis / complications
  • Colitis / prevention & control*
  • Colon / cytology
  • Colon / drug effects
  • Colon / pathology
  • Colonic Neoplasms / chemically induced
  • Colonic Neoplasms / prevention & control*
  • Colorectal Neoplasms / prevention & control*
  • Cyclooxygenase Inhibitors / administration & dosage
  • Cyclooxygenase Inhibitors / therapeutic use*
  • Intestinal Mucosa / cytology
  • Intestinal Mucosa / drug effects
  • Intestinal Mucosa / pathology
  • Male
  • Mice
  • Mice, Inbred CBA
  • Sulindac / administration & dosage
  • Sulindac / therapeutic use*
  • Water Supply

Substances

  • Carcinogens
  • Cyclooxygenase Inhibitors
  • Sulindac
  • Azoxymethane